Cargando…
The impact of COVID-19 pandemic on patients with ANCA associated vasculitis
INTRODUCTION: The coronavirus 2019 (COVID-19) pandemic has brought on challenges not only to acute care, but also chronic care of patients. Individuals maintained on immunosuppression appear to be especially susceptible to COVID-19 infection. Patients with ANCA-associated vasculitis (AAV) frequently...
Autores principales: | Kant, Sam, Morris, Adam, Ravi, Srekar, Floyd, Lauren, Gapud, Eric, Antichos, Brendan, Dhaygude, Ajay, Seo, Phil, Geetha, Duvuru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543954/ https://www.ncbi.nlm.nih.gov/pubmed/33034038 http://dx.doi.org/10.1007/s40620-020-00881-3 |
Ejemplares similares
-
Subcutaneous Immunoglobulin for Antibody Deficiency in Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis
por: Kant, Sam, et al.
Publicado: (2019) -
Cardiovascular disease and ANCA-associated vasculitis: are we missing a beat?
por: Floyd, Lauren, et al.
Publicado: (2022) -
ANCA Vasculitis Induction Management During the COVID-19 Pandemic
por: Salas, Antonio, et al.
Publicado: (2021) -
SARS-CoV-2 Vaccine Response in Patients With Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
por: Floyd, Lauren, et al.
Publicado: (2021) -
Levamisole adulterated cocaine associated ANCA vasculitis: review of literature and update on pathogenesis
por: Jin, Qiuyu, et al.
Publicado: (2018)